SAMPSON PETER BRENT,LIU YONG,LI SZE-WAN,FORREST BRYAN T.,PAULS HEINZ W.,EDWARDS LOUISE G.,FEHER MIKLOS,PATEL NARENDRA KUMAR B.,LAUFER RADOSLAW,PAN GUOHUA,FEHER M
申请号：
PL11764988
公开号：
PL2556071T3
申请日:
2011.04.06
申请国别(地区):
PL
年份:
2017
代理人:
摘要：
The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof: Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
